Abstract
The manufacturing of the antiepileptics, carbamazepine (CBZ) and oxcarbazepine (oxCBZ), results in generation of wastewater containing these micropollutants which exhibit toxicity even at trace levels. Therefore, we focused on monitoring their fate and removal in various units of a full-scale wastewater treatment plant (WWTP) using mass balance approach. An apparent CBZ removal of 50±3% was observed by conventional activated sludge process in the biological treatment unit, whereas oxCBZ still persisted after the biological treatment and showed negative mass balance. However, reverse osmosis resulted in 91% oxCBZ removal, whereas CBZ still continued to persist as a result of lower solubility of CBZ as compared to oxCBZ. Only 3% CBZ exhibited sorption onto the suspended solids and sludge, which was negligible for oxCBZ, thus demonstrating their tendency to remain in aqueous phase. Additionally, we attempted to understand the fundamental mechanism behind the removal of these pharmaceuticals and it was apparently the collective effect of sorption, mineralization, biotransformation, biodegradation, phototransformation/photodegradation, etc. Thus, the integrative data presented in the present study on productivity of these pharmaceuticals, their mass loading in influent and effluents allied with their removal efficiency will be significantly constructive in benchmarking the operational effectiveness through operational optimization and design improvement of the current conventional treatment plant.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
O. Paltiel, G. Fedorova, G. Tadmor, G. Kleinstern, Y. Maor and B. Chefetz, Environ. Sci. Technol., 50(8), 4476 (2016).
C. M. de Jongh, P. J. F. Kooij, P. de Voogt and T. L. ter Laak, Sci. Total Environ., 427, 70 (2012).
J. Fick, H. Söderström, R. H. Lindberg, C. Phan, M. Tysklind and D.G. J. Larsson, Environ. Toxicol. Chem., 28(12), 2522 (2009).
A.M. Deegan, B. Shaik, K. Nolan, K. Urell, M. Oelgemoller, J. Tobin and A. Morrissey, Int. J. Environ. Sci. Technol., 8(3), 649 (2011).
A. Jelic, M. Gros, M. Petrovic, A. Ginebreda and D. Barceló, in Emerging and priority pollutants in rivers, H. Guasch, A. Ginebreda and A. Geiszinger Eds., The Handbook of Environmental Chemistry, 19, 1 (2012).
G. Knopp, C. Prasse, T.A. Ternes and P. Cornel, Water Res., 100, 580 (2016).
C. Gadipelly, A. Pérez-González, G.D. Yadav, I. Ortiz, R. Ibáñez, V. K. Rathod and K.V. Marathe, Ind. Eng. Chem. Res., 53(29), 11571 (2014).
Y. Zhang, S.U. Geißen and C. Gal, Chemosphere, 73, 1151 (2008).
X. S. Miao, J. J. Yang and C.D. Metcalfe, Environ. Sci. Technol., 39, 7469 (2005).
M. Leclercq, O. Mathieu, E. Gomez, C. Casellas, H. Fenet and D. Hillaire-Buys, Arch. Environ. Contam. Toxicol., 56, 408 (2009).
N. Collado, S. Rodriguez-Mozaz, M. Gros, A. Rubirola, D. Barceló, J. Comas, I. Rodriguez-Roda and G. Buttiglieri, Environ. Pollut., 185, 202 (2014).
R. Gurke, M. Rößler, C. Marx, S. Diamond, S. Schubert, R. Oertel and J. Fauler, Sci. Total Environ., 532, 762 (2015).
P. J. Phillips, S. G. Smith, D.W. Koplin, S.D. Zaugg, H.T. Buxton, E.T. Furlong, K. Esposito and B. Stinson, Environ. Sci. Technol., 44(13), 4910 (2010).
S. Puig, M. C. M. Loosdrecht, J. Colprim and S. C. F. Meijer, Water Res., 42(18), 4645 (2008).
M. Cirja, P. Ivaschechkin, A. Schäffer and P.F.X. Corvini, Rev. Environ. Sci. Biotechnol., 7(1), 61 (2008).
C. Klein, S. O’Connor and J. Locke, in Fate of pharmaceuticals in the environment and in water treatment systems, D. S. Aga Ed., CRC Press, New York (2008).
J. Deng, Y. Shao, N. Gao, S. Xia, C. Tan, S. Zhou and X. Hu, Chem. Eng. J., 222, 150 (2013).
M. Bernhard, J. Müller and T. P. Knepper, Water Res., 40(18), 3419 (2006).
S.K. Behera, H.W. Kim, J. Oh and H. Park, Sci. Total Environ., 409(20), 4351 (2011).
N. Paxéus, Water Sci. Technol., 50(5), 253 (2004).
M. Clara, B. Strenn and N. Kreuzinger, Water Res., 38(4), 947 (2004).
C. Marx, N. Günther, S. Schubert, R. Oertel, M. Ahnert, P. Krebs and V. Kuehn, Sci. Total Environ., 538, 779 (2015).
P. Verlicchi, M. A. Aukidy and E. Zambello, Sci. Total Environ., 429, 123 (2012).
T.A. Ternes, N. Herrmann, M. Bonerz, T. Knacker, H. Siegrist and A. Joss, Water Res., 38(19), 4075 (2004).
A. Joss, E. Keller, A. C. Alder, A. Göbel, C. S. McArdell, T. Ternes and H. Siegrist, Water Res., 39(14), 3139 (2005).
POSEIDON Final Report, T. Ternes, Contract No. EVK1-CT-2000-00047 (2006).
E.D. Laurentiis, S. Chiron, S. Kouras-Hadef, C. Richard, M. Minella, V. Maurino, C. Minero and D. Vione, Environ. Sci. Technol., 46(15), 8164 (2012).
J. Heidler and R.U. Halden, Environ. Sci. Technol., 42(17), 6324 (2008).
E. Kaiser, C. Prasse, M. Wagner, K. Bröder and T. A. Ternes, Environ. Sci. Technol., 48(17), 10208 (2014).
Z. Li, H. Fenet, E. Gomez and S. Chiron, Water Res., 45(4), 1587 (2011).
U. Hübner, B. Seiwert, T. Reemtsma and M. Jekel, Water Res., 49, 34 (2014).
V.M. Monsalvo, J. Lopez, M. Munoz, Z. M. de Pedro, J. A. Casas, A. F. Mohedano and J. J. Rodriguez, Chem. Eng. J., 264, 856 (2015).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
11814_2017_190_MOESM1_ESM.pdf
Carbamazepine and oxcarbazepine removal in pharmaceutical wastewater treatment plant using a mass balance approach: A case study
Rights and permissions
About this article
Cite this article
Dwivedi, K., Morone, A., Pratape, V. et al. Carbamazepine and oxcarbazepine removal in pharmaceutical wastewater treatment plant using a mass balance approach: A case study. Korean J. Chem. Eng. 34, 2662–2671 (2017). https://doi.org/10.1007/s11814-017-0190-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-017-0190-2